Search
Search
About
Log in
Join
Experiences with
Xenical
Posts
Communities
1,358 public posts
Filter results
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
The market for the new class of hepatitis-C drugs is becoming more crowded as a higher percentage of patients seek out therapies with shorter treatment durations and drugmakers pursue indications for more stubborn forms of the infection. Gilead Sciences, which developed Sovaldi and Harvoni, the current
The market for the new class of hepatitis-C drugs is becoming more crowded as a higher percentage of patients seek out therapies with shorter treatment durations and drugmakers pursue indications for more stubborn forms of the infection. Gilead Sciences, which developed Sovaldi and Harvoni, the current
kcohen
in
HFI Connect - Hepatitis
9 years ago
Gilead Won’t Run Out of Hep C Patients, or Dollars, Anytime Soon
A single pill of Gilead Sciences Inc.’s hepatitis C treatment costs more than an iPhone, and is selling better, too. In the drug’s first full year on the market in 2014, Sovaldi — which costs $1,000 a pill — brought in $10.3 billion. That’s more than the Apple Inc. phone generated in 2008, its first
A single pill of Gilead Sciences Inc.’s hepatitis C treatment costs more than an iPhone, and is selling better, too. In the drug’s first full year on the market in 2014, Sovaldi — which costs $1,000 a pill — brought in $10.3 billion. That’s more than the Apple Inc. phone generated in 2008, its first
kcohen
in
HFI Connect - Hepatitis
9 years ago
FDA OK’s BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3
The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb’s (BMS) NS5A inhibitor Daklinza (daclatasvir) to be used in combination with Gilead Sciences’ Sovaldi (sofosbuvir) to treat genotype 3 of hepatitis C. This is the first hep C regimen ever to be specifically approved for genotype
The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb’s (BMS) NS5A inhibitor Daklinza (daclatasvir) to be used in combination with Gilead Sciences’ Sovaldi (sofosbuvir) to treat genotype 3 of hepatitis C. This is the first hep C regimen ever to be specifically approved for genotype
kcohen
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Anyone tried CBD Oil?
Must be a couple of years since I posted on here - at that time I'd progressed from unsatisfactory Ropinirole to the then-new Neupro 3mg transdermal patch, at which point I thought I'd cracked it. However, over the last few weeks the patches seem to have lost their efficacy - got no sleep at all last
Must be a couple of years since I posted on here - at that time I'd progressed from unsatisfactory Ropinirole to the then-new Neupro 3mg transdermal patch, at which point I thought I'd cracked it. However, over the last few weeks the patches seem to have lost their efficacy - got no sleep at all last
Hidden
in
Restless Legs Syndrome
9 years ago
NEW HEPATITIS C DRUG SHOWS HOW BIG PHARMA GOUGES SICK PEOPLE
Gilead Sciences trumpets Harvoni, its newest Hepatitis C med, as a wonder drug. It's the first-ever once-daily pill, an improvement over predecessor Sovaldi, which requires a sidecar of injections. Cleanliness of dosing comes with a tradeoff. Harvoni costs $1,350 per pill, or $350 a pop more than its
Gilead Sciences trumpets Harvoni, its newest Hepatitis C med, as a wonder drug. It's the first-ever once-daily pill, an improvement over predecessor Sovaldi, which requires a sidecar of injections. Cleanliness of dosing comes with a tradeoff. Harvoni costs $1,350 per pill, or $350 a pop more than its
kcohen
in
HFI Connect - Hepatitis
9 years ago
HIV Meds Should Work for Most Drug-Resistant Strains in the UK
Drug-resistant strains of HIV continue to be transmitted in the United Kingdom, but this does not appear likely to have a major effect on the response to antiretroviral (ARV) treatment, aidsmap reports. Publishing their findings in Clinical Infectious Diseases, researchers examined 1,140 samples of drug-resistant
Drug-resistant strains of HIV continue to be transmitted in the United Kingdom, but this does not appear likely to have a major effect on the response to antiretroviral (ARV) treatment, aidsmap reports. Publishing their findings in Clinical Infectious Diseases, researchers examined 1,140 samples of drug-resistant
kcohen
in
HFI Connect - Hepatitis
9 years ago
6 Positive Life Changes That Come With HIV: by Alex Garner
The founding editor of Positive Frontiers wants an honest conversation about living with HIV. Receiving the news that you are HIV positive is life changing. Some people experience profound fear and shame upon hearing the news, but they don't have to. Let's stop scaring negative men about the "woes and
The founding editor of Positive Frontiers wants an honest conversation about living with HIV. Receiving the news that you are HIV positive is life changing. Some people experience profound fear and shame upon hearing the news, but they don't have to. Let's stop scaring negative men about the "woes and
kcohen
in
HFI Connect - Hepatitis
9 years ago
Going Gold for HIV
Each year the city of Vienna hosts Life Ball, Europe’s biggest HIV/AIDS charity event. Now in its 23rd year, Life Ball creates public awareness for HIV/AIDS and raises funds to support HIV-related projects in Austria and around the world. The theme of this year’s Life Ball, held on May 16, was inspired
Each year the city of Vienna hosts Life Ball, Europe’s biggest HIV/AIDS charity event. Now in its 23rd year, Life Ball creates public awareness for HIV/AIDS and raises funds to support HIV-related projects in Austria and around the world. The theme of this year’s Life Ball, held on May 16, was inspired
kcohen
in
HFI Connect - Hepatitis
9 years ago
Former College Wrestler Gets 30 Years in HIV Case
Michael Johnson, a former university wrestler in St. Charles, Missouri, was sentenced to 30 years in prison for infecting one sex partner with HIV and for putting four others at risk, reports the St. Louis Post-Dispatch. During the trial earlier this year, the jury had recommended 30 years for the most
Michael Johnson, a former university wrestler in St. Charles, Missouri, was sentenced to 30 years in prison for infecting one sex partner with HIV and for putting four others at risk, reports the St. Louis Post-Dispatch. During the trial earlier this year, the jury had recommended 30 years for the most
kcohen
in
HFI Connect - Hepatitis
9 years ago
Las Vegas Hepatitis C Outbreak Doctor Gets Additional 71 Months in Federal Prison
Dipak Desai — the former gastroenterologist responsible for a 2007 outbreak of the hepatitis C virus (HCV) in Nevada — has been sentenced an additional 71 months in federal prison for his role in a multimillion-dollar health care fraud scheme tied to the string of infections, the Las Vegas Review Journal
Dipak Desai — the former gastroenterologist responsible for a 2007 outbreak of the hepatitis C virus (HCV) in Nevada — has been sentenced an additional 71 months in federal prison for his role in a multimillion-dollar health care fraud scheme tied to the string of infections, the Las Vegas Review Journal
kcohen
in
HFI Connect - Hepatitis
9 years ago
Early HIV Treatment Especially Benefits Older People
Starting HIV treatment with a high viral load leads to a much greater reduction in death rates for people ages 45 to 65, compared with younger people with HIV, aidsmap reports. Publishing their findings in Clinical Infectious Diseases, researchers compared 10-year mortality rates with CD4 counts upon
Starting HIV treatment with a high viral load leads to a much greater reduction in death rates for people ages 45 to 65, compared with younger people with HIV, aidsmap reports. Publishing their findings in Clinical Infectious Diseases, researchers compared 10-year mortality rates with CD4 counts upon
kcohen
in
HFI Connect - Hepatitis
9 years ago
Concerns Over State Restrictions on New Hepatitis C Drugs
State Medicaid programs across the United States may be putting up illegal barriers to prevent low-income people from getting access to expensive new hepatitis C virus (HCV) treatments, suggests a new study published in Annals of Internal Medicine. According to experts, state cost-saving restrictions
State Medicaid programs across the United States may be putting up illegal barriers to prevent low-income people from getting access to expensive new hepatitis C virus (HCV) treatments, suggests a new study published in Annals of Internal Medicine. According to experts, state cost-saving restrictions
kcohen
in
HFI Connect - Hepatitis
9 years ago
Most U.S. Hepatitis C Cases Not Reported to CDC
The number of acute hepatitis C virus (HCV) cases reported to the U.S. Centers for Disease Control and Prevention (CDC) are just the “tip of the iceberg” when it comes to the overall burden of the liver disease. According to a new study published in the Annals of Internal Medicine, the actual number
The number of acute hepatitis C virus (HCV) cases reported to the U.S. Centers for Disease Control and Prevention (CDC) are just the “tip of the iceberg” when it comes to the overall burden of the liver disease. According to a new study published in the Annals of Internal Medicine, the actual number
kcohen
in
HFI Connect - Hepatitis
9 years ago
Thumbs
Hi all does anyone have carpel tunnel syndrome . I have really painful hands lately my wonderful doc thinks that what it is . The pain is between my thumbs an first finger also wrists
Hi all does anyone have carpel tunnel syndrome . I have really painful hands lately my wonderful doc thinks that what it is . The pain is between my thumbs an first finger also wrists
Hidden
in
Thyroid UK
9 years ago
Medical Marijuana In Birningham Englad
I have a dear friend's mom who is dying in Biringham and he is going home to see her. Does anyone know the system in England and whether doctors will give medical maijuana to patients to help them eat, gain wait, relax, sleep better throughout the night? If you have any advice he leave s this week. Thanks
I have a dear friend's mom who is dying in Biringham and he is going home to see her. Does anyone know the system in England and whether doctors will give medical maijuana to patients to help them eat, gain wait, relax, sleep better throughout the night? If you have any advice he leave s this week. Thanks
nancyjo
in
CLL Support
9 years ago
S.F. Sees Lowest Rates Ever of New HIV Diagnoses and Deaths
In 2014, San Francisco recorded 302 new HIV diagnoses and 177 deaths of HIV-positive people; these are the lowest-ever numbers in the city’s history of the epidemic and amount to a 17 percent drop from the previous year, reports the San Francisco Examiner. The data arrive from the city’s Department
In 2014, San Francisco recorded 302 new HIV diagnoses and 177 deaths of HIV-positive people; these are the lowest-ever numbers in the city’s history of the epidemic and amount to a 17 percent drop from the previous year, reports the San Francisco Examiner. The data arrive from the city’s Department
kcohen
in
HFI Connect - Hepatitis
9 years ago
Gilead Seeks FDA OK for 3rd Combo Pill With New Tenofovir
Gilead Sciences has applied to the U.S. Food and Drug Administration (FDA) for approval of yet another combination HIV tablet including an updated version of tenofovir. Intended for adults and children 12 years or older, the single-tablet regimen combines Gilead’s Emtriva (emtricitabine) and the investigational
Gilead Sciences has applied to the U.S. Food and Drug Administration (FDA) for approval of yet another combination HIV tablet including an updated version of tenofovir. Intended for adults and children 12 years or older, the single-tablet regimen combines Gilead’s Emtriva (emtricitabine) and the investigational
kcohen
in
HFI Connect - Hepatitis
9 years ago
Interactive Maps to See the Latest HIV Data
AIDSVu launched new interactive maps of HIV prevalence data for the 34 U.S. cities most affected by the epidemic, including state and county data and year-by-year diagnosis information for 2008 to 2013. A project of Emory University’s Rollins School of Public Health, along with Gilead Sciences, the
AIDSVu launched new interactive maps of HIV prevalence data for the 34 U.S. cities most affected by the epidemic, including state and county data and year-by-year diagnosis information for 2008 to 2013. A project of Emory University’s Rollins School of Public Health, along with Gilead Sciences, the
kcohen
in
HFI Connect - Hepatitis
9 years ago
Nation's Capital Sees 'Remarkable' Drop in New HIV Cases
By most measures, Washington, DC, is making major progress in its fight against HIV, according to new data released by the city and reported in the Washington Post. From 2012 to 2013, the latest date available, newly diagnosed cases per year dropped from 678 to 553. This represents a 40 percent decline
By most measures, Washington, DC, is making major progress in its fight against HIV, according to new data released by the city and reported in the Washington Post. From 2012 to 2013, the latest date available, newly diagnosed cases per year dropped from 678 to 553. This represents a 40 percent decline
kcohen
in
HFI Connect - Hepatitis
9 years ago
State Moves To Make Costly Hepatitis C Drugs More Accessible To Medicaid Patients
onnecticut is poised to make a new class of costly hepatitis C drugs more accessible to the state's poorest patients. The state Department of Social Services will classify Sovaldi, Harvoni and Viekira Pak as preferred drugs in its Medicaid program, which means they will be "readily available to our
onnecticut is poised to make a new class of costly hepatitis C drugs more accessible to the state's poorest patients. The state Department of Social Services will classify Sovaldi, Harvoni and Viekira Pak as preferred drugs in its Medicaid program, which means they will be "readily available to our
kcohen
in
HFI Connect - Hepatitis
9 years ago
1
...
56
57
58
...
68
Next page
10
20
30
40
50
60
Filter results
Clear filters
Posted in
All communities
Restless Legs Syndrome
150 results
Advanced Prostate Cancer
114 results
Cure Parkinson's
98 results
View top 10 communities
Sort by
Most Relevant
Newest